538634 Board Approves Q4 FY26 Results, New Director, Mfg MoU

The Board of Directors of 538634, at their meeting on May 28, 2026, approved the Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026, with an unmodified opinion. The Board appointed Mr. Ravi Jain as an Additional Non-Executive Independent Director and noted the retirement of Mr. Pradeep Kumar Jain. Furthermore, the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee were reconstituted, with Mr. Manish Jain appointed as chairperson for all three. A Memorandum of Understanding cum Loan-Lease Agreement with PandJ Cretechem Private Limited (Holding Company) for Active Pharmaceutical Ingredients (APIs) manufacturing at Dahej, Gujarat, was also approved.